Key facts
- This page summarizes Daljit Singh Aurora's Form 4 filing for Neumora Therapeutics, Inc. (NMRA).
- 15 reported transactions and 6 derivative rows are listed below.
- Accepted by SEC: 21 Aug 2026, 19:10.
Daljit Singh Aurora - 20 Aug 2026 Form 4 Insider Report for Neumora Therapeutics, Inc. (NMRA)
- Reporting relationship
- Title: Chief Operating and Development Officer
- Issuer ticker
- NMRA
- Reported as of
- 20 Aug 2026
- Net transaction value
- -$269,967
- SEC form
- 4
- Accepted by SEC
- 21 Aug 2026, 19:10:48 UTC
- Prior SEC filing
- 19 Aug 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Michael Milligan, as Attorney-in-Fact for Daljit Singh Aurora
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Daljit Singh Aurora filed Form 4 for Neumora Therapeutics, Inc. (NMRA) on 21 Aug 2026.
Change
- Previous filing in this sequence was filed on 19 Aug 2026.
- Current net transaction value: -$269,967.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001793971
Primary reporting owner
Aurora Daljit Singh
- Relationship
- Title: Chief Operating and Development Officer
- Address
- C/O NEUMORA THERAPEUTICS, INC., 260 ARSENAL PLACE, SUITE 1, WATERTOWN
- Signature
- /s/ Michael Milligan, as Attorney-in-Fact for Daljit Singh Aurora
- Signature date
- 21 Aug 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
NMRA
transaction
Common Stock
Options Exercise
- Transaction value
- Shares
- +67,741
- Change %
- +139%
- Price
- $0.7200*
- Shares after
- 116,491
- Date
- 20 Aug 2026
- Ownership
- Direct
NMRA
transaction
Common Stock
Sale
- Transaction value
- $102,587
- Shares
- -67,741
- Change %
- -58%
- Price
- $1.51
- Shares after
- 48,750
- Date
- 20 Aug 2026
- Ownership
- Direct
- Footnotes
- F1
NMRA
transaction
Common Stock
Options Exercise
- Transaction value
- Shares
- +21,685
- Change %
- Price
- $0.7200*
- Shares after
- 21,685
- Date
- 20 Aug 2026
- Ownership
- See footnote
- Footnotes
- F3
NMRA
transaction
Common Stock
Options Exercise
- Transaction value
- Shares
- +45,026
- Change %
- +208%
- Price
- $0.7200*
- Shares after
- 66,711
- Date
- 20 Aug 2026
- Ownership
- See footnote
- Footnotes
- F3
NMRA
transaction
Common Stock
Sale
- Transaction value
- $101,000
- Shares
- -66,711
- Change %
- -100%
- Price
- $1.51
- Shares after
- 0
- Date
- 20 Aug 2026
- Ownership
- See footnote
- Footnotes
- F2, F3
NMRA
transaction
Common Stock
Options Exercise
- Transaction value
- Shares
- +20,553
- Change %
- +42%
- Price
- $0.7200*
- Shares after
- 69,303
- Date
- 21 Aug 2026
- Ownership
- Direct
NMRA
transaction
Common Stock
Sale
- Transaction value
- $32,780
- Shares
- -20,553
- Change %
- -30%
- Price
- $1.59
- Shares after
- 48,750
- Date
- 21 Aug 2026
- Ownership
- Direct
- Footnotes
- F7
NMRA
transaction
Common Stock
Options Exercise
- Transaction value
- Shares
- +21,055
- Change %
- Price
- $0.7200*
- Shares after
- 21,055
- Date
- 21 Aug 2026
- Ownership
- See footnote
- Footnotes
- F3
NMRA
transaction
Common Stock
Sale
- Transaction value
- $33,600
- Shares
- -21,055
- Change %
- -100%
- Price
- $1.60
- Shares after
- 0
- Date
- 21 Aug 2026
- Ownership
- See footnote
- Footnotes
- F3, F8
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
NMRA
transaction
Derivative
Stock Option (Right to Buy)
Options Exercise
- Transaction value
- Shares
- -67,741
- Change %
- -38%
- Price
- $0.000000*
- Shares after
- 109,527
- Date
- 20 Aug 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 67,741
- Exercise price
- $0.7200
- Footnotes
- F4
NMRA
transaction
Derivative
Stock Option (Right to Buy)
Options Exercise
- Transaction value
- Shares
- -45,026
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 0
- Date
- 20 Aug 2026
- Ownership
- See footnote
- Underlying class
- Common Stock
- Underlying amount
- 45,026
- Exercise price
- $0.7200
- Footnotes
- F3, F5
NMRA
transaction
Derivative
Stock Option (Right to Buy)
Options Exercise
- Transaction value
- Shares
- -21,685
- Change %
- -16%
- Price
- $0.000000*
- Shares after
- 115,853
- Date
- 20 Aug 2026
- Ownership
- See footnote
- Underlying class
- Common Stock
- Underlying amount
- 21,685
- Exercise price
- $0.7200
- Footnotes
- F3, F5
NMRA
transaction
Derivative
Stock Option (Right to Buy)
Award
- Transaction value
- Shares
- +200,000
- Change %
- Price
- $0.000000*
- Shares after
- 200,000
- Date
- 20 Aug 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 200,000
- Exercise price
- $1.52
- Footnotes
- F6
NMRA
transaction
Derivative
Stock Option (Right to Buy)
Options Exercise
- Transaction value
- Shares
- -20,553
- Change %
- -19%
- Price
- $0.000000*
- Shares after
- 88,974
- Date
- 21 Aug 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 20,553
- Exercise price
- $0.7200
- Footnotes
- F4
NMRA
transaction
Derivative
Stock Option (Right to Buy)
Options Exercise
- Transaction value
- Shares
- -21,055
- Change %
- -18%
- Price
- $0.000000*
- Shares after
- 94,798
- Date
- 21 Aug 2026
- Ownership
- See footnote
- Underlying class
- Common Stock
- Underlying amount
- 21,055
- Exercise price
- $0.7200
- Footnotes
- F3, F5
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 8 footnotes
Footnote F1
This transaction was executed in multiple trades at prices ranging from $1.485 to $1.625, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
Footnote F2
This transaction was executed in multiple trades at prices ranging from $1.48 to $1.6252, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
Footnote F3
Shares held by Aurora Family Trust, of which members of the Reporting Person's immediate family are the sole beneficiaries.
Footnote F4
25% of the shares subject to the option vest on the first anniversary measured from February 14, 2024 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.
Footnote F5
The stock option is fully vested and exercisable.
Footnote F6
25% of the shares subject to the option vest on the first anniversary measured from August 20, 2026 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.
Footnote F7
This transaction was executed in multiple trades at prices ranging from $1.51 to $1.6379, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
Footnote F8
This transaction was executed in multiple trades at prices ranging from $1.51 to $1.6393, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
SEC remarks
Title: Chief Operating and Development Officer